NO20015181L - Expression of heparin-binding protein in recombinant mammalian cells - Google Patents
Expression of heparin-binding protein in recombinant mammalian cellsInfo
- Publication number
- NO20015181L NO20015181L NO20015181A NO20015181A NO20015181L NO 20015181 L NO20015181 L NO 20015181L NO 20015181 A NO20015181 A NO 20015181A NO 20015181 A NO20015181 A NO 20015181A NO 20015181 L NO20015181 L NO 20015181L
- Authority
- NO
- Norway
- Prior art keywords
- binding protein
- expression
- cell
- heparin
- mammalian cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Foreliggende oppfinnelse omhandler en fremgangsmåte for å fremstille et pattedyr heparinbindende protein i en pattedyrcelle som kan bli dyrket under anaerobe betingelser etter å ha introdusert en nukleinsyre som koder som heparinbindende protein inn i nevnte celle som omfatter (a) å introdusere inn i nevnte pattedyrcelle en nukleinsyre som koder for nevnte heparinbindende protein; (b) å dyrke cellen fra trinn (a) under betingelser som er fremmende for ekspresjon av nevnte HBP; og (c) å gjenvinne nevnte HBP fra dyrkningsmediet. Videre omhandler oppfinnelsen den rekombinante pattedyrcellen som blir benyttet i fremgangsmåten.The present invention relates to a process for producing a mammalian heparin binding protein in a mammalian cell which can be cultured under anaerobic conditions after introducing a nucleic acid encoding as heparin binding protein into said cell which comprises (a) introducing into said mammalian cell a nucleic acid cell encoding said heparin binding protein; (b) culturing the cell of step (a) under conditions conducive to expression of said HBP; and (c) recovering said HBP from the culture medium. Furthermore, the invention relates to the recombinant mammalian cell used in the method.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13157499P | 1999-04-29 | 1999-04-29 | |
DKPA199900612 | 1999-05-06 | ||
PCT/DK2000/000216 WO2000066627A1 (en) | 1999-04-29 | 2000-04-28 | Expression of heparin-binding protein in recombinant mammalian cells |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015181D0 NO20015181D0 (en) | 2001-10-23 |
NO20015181L true NO20015181L (en) | 2001-12-20 |
Family
ID=26064312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015181A NO20015181L (en) | 1999-04-29 | 2001-10-23 | Expression of heparin-binding protein in recombinant mammalian cells |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1179017A1 (en) |
JP (1) | JP2002542813A (en) |
KR (1) | KR20020034073A (en) |
CN (1) | CN1357007A (en) |
AU (1) | AU4286100A (en) |
CA (1) | CA2407714A1 (en) |
EA (1) | EA200101093A1 (en) |
HK (1) | HK1046005A1 (en) |
IL (1) | IL146128A0 (en) |
NO (1) | NO20015181L (en) |
NZ (1) | NZ515762A (en) |
PL (1) | PL351499A1 (en) |
WO (1) | WO2000066627A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003226907A1 (en) * | 2002-03-27 | 2003-10-08 | Leukotech A/S | Method for the preparation of recombinant mammalian heparin-binding protein (hbp) |
EP1739179A1 (en) * | 2005-06-30 | 2007-01-03 | Octapharma AG | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
GB201102108D0 (en) * | 2011-02-07 | 2011-03-23 | Hansa Medical Ab | Diagnostic method |
CN110643586B (en) * | 2019-10-15 | 2022-06-10 | 山东大学 | Heparin skeleton synthase and coding gene and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0409858B1 (en) * | 1988-03-17 | 1993-12-08 | Novo Nordisk A/S | Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them |
DE69530689T2 (en) * | 1994-04-21 | 2004-03-25 | Leukotech A/S | HEPARIN BINDING PROTEIN FOR TREATING SEPSIS |
WO1999000417A1 (en) * | 1997-06-25 | 1999-01-07 | Novo Nordisk A/S | Production of heparin-binding protein in mammalian cells |
-
2000
- 2000-04-28 EP EP00922473A patent/EP1179017A1/en not_active Withdrawn
- 2000-04-28 CA CA002407714A patent/CA2407714A1/en not_active Abandoned
- 2000-04-28 PL PL00351499A patent/PL351499A1/en not_active Application Discontinuation
- 2000-04-28 IL IL14612800A patent/IL146128A0/en unknown
- 2000-04-28 AU AU42861/00A patent/AU4286100A/en not_active Abandoned
- 2000-04-28 WO PCT/DK2000/000216 patent/WO2000066627A1/en not_active Application Discontinuation
- 2000-04-28 KR KR1020017013766A patent/KR20020034073A/en not_active Application Discontinuation
- 2000-04-28 NZ NZ515762A patent/NZ515762A/en unknown
- 2000-04-28 EA EA200101093A patent/EA200101093A1/en unknown
- 2000-04-28 JP JP2000615655A patent/JP2002542813A/en active Pending
- 2000-04-28 CN CN00809227A patent/CN1357007A/en active Pending
-
2001
- 2001-10-23 NO NO20015181A patent/NO20015181L/en not_active Application Discontinuation
-
2002
- 2002-10-16 HK HK02107495.3A patent/HK1046005A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1046005A1 (en) | 2002-12-20 |
JP2002542813A (en) | 2002-12-17 |
NZ515762A (en) | 2002-11-26 |
CA2407714A1 (en) | 2000-11-09 |
EP1179017A1 (en) | 2002-02-13 |
NO20015181D0 (en) | 2001-10-23 |
EA200101093A1 (en) | 2002-04-25 |
WO2000066627A1 (en) | 2000-11-09 |
PL351499A1 (en) | 2003-04-22 |
CN1357007A (en) | 2002-07-03 |
KR20020034073A (en) | 2002-05-08 |
AU4286100A (en) | 2000-11-17 |
IL146128A0 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ597334A (en) | Cell culture improvements | |
WO1998014602A3 (en) | Preparation of d-amino acids by direct fermentative means | |
DE69939947D1 (en) | METHOD OF PREPARING POLYPEPTIDES IN MUTATED ASPERGILLUS CELLS | |
ATE466094T1 (en) | METHOD FOR PRODUCING OLIGOSACCHARIDES | |
NO20072719L (en) | Serum-free cell culture medium for mammalian cells | |
DK0956338T3 (en) | Host cells and methods for producing proteins | |
TW200500462A (en) | Method for producing target substance by fermentation | |
AU5102899A (en) | Process and materials for production of glucosamine | |
ATE375385T1 (en) | USE OF A SERUM-FREE CELL CULTURE MEDIUM FOR PRODUCTION OF IL-18BP IN MAMMAL CELLS | |
BR0012712A (en) | Methods of producing l-amino acids by increasing cellular nadph | |
WO2004090096A3 (en) | Methods for neural differentiation of embryonic stem cells using protease passaging techniques | |
DE69938127D1 (en) | MICROBIAL STRAINS AND METHOD FOR THE PRODUCTION OF BIOMATERIALS | |
DE60041821D1 (en) | PLURIPOTENT EMBRYONAL STEM CELL-SIMILAR CELLS, COMPOSITIONS, AND ITS CONDITIONS | |
ATE246251T1 (en) | METHOD FOR PRODUCING POLYPEPTIDES IN SURFACTIN MUTANTS OF BACILLUS CELLS | |
AU4940096A (en) | Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production | |
DK1495112T3 (en) | Cell Culture Medium | |
ATE486935T1 (en) | MICROORGANISM STRAIN FOR THE PRODUCTION OF RECOMBINANT PROTEINS | |
NO20015181L (en) | Expression of heparin-binding protein in recombinant mammalian cells | |
NZ522337A (en) | Production of TcR gamma delta T cells | |
ATE299178T1 (en) | METHOD FOR PRODUCING MAMMAL CELL LINES | |
EA200701000A1 (en) | CULTURAL MEDIUM FOR MAMMAL CELLS, NOT CONTAINING SERUM | |
FR2857671B1 (en) | NOVEL METHOD FOR CULTURING KERATINOCYTES AND ITS APPLICATIONS | |
WO2002064811A3 (en) | Method for producing recombinant proteins marked with at least one isotope | |
Vidova et al. | Harmaline‐resistant mutant of Methanothermobacter thermautotrophicus with a lesion in Na (+)/H (+) antiport | |
WO2003012098A1 (en) | Modified yeast showing high secretion productivity of foreign protein and process for producing foreign protein using the yeast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |